Multiple myeloma and cardiovascular risk (a literature review)

• Váldodahkkit: B. B. Samura (Dahkki), M. O. Panasenko (Dahkki), S. Ya. Dotsenko (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Zaporozhye State Medical University, 2020-11-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Multiple myeloma is a plasma cell clonal malignancy that accounts for 10 % of hematological cancers. It predominantly affects elderly people; median age at diagnosis is 70 years. Consequently, many patients with MM have cardiovascular comorbidities or risk factors. MM can cause cardiac comorbidities...